Print Page

Letters to Healthcare Providers
 
Isotretinoin (Roaccutane): rare reports of erectile dysfunction and decreased libido (Letter to Healthcare Professionals)
 
 
 
Attachment:
  1. Isotretinoin (Roaccutane): rare reports of erectile dysfunction and decreased libido  
Related Information:
The United Kingdom: Isotretinoin – changes to prescribing guidance and additiona... Posted 2026-01-23
中國：國家藥監局關於修訂異維A酸軟膠囊說明書的公告（2026年第2號）(Chinese only) Posted 2026-01-07
Australia: New safety warnings for isotretinoin (Roaccutane) Posted 2025-04-08
Canada: Summary Safety Review: Isotretinoin: Assessing the potential risk of sex... Posted 2024-07-26
Singapore: HSA: Isotretinoin and risk of psychiatric disorders and sexual dysfun... Posted 2023-12-16
The United Kingdom: Isotretinoin (Roaccutane▼): introduction of new safety measu... Posted 2023-11-01
The United Kingdom: Isotretinoin (Roaccutane▼): new safety measures to be introd... Posted 2023-04-27
Isotretinoin (Roaccutane▼): new safety measures to be introduced in the coming m... Posted 2023-04-27
The United Kingdom: Isotretinoin: an expert review of suspected psychiatric and ... Posted 2020-11-11
The United Kingdom: Isotretinoin (Roaccutane▼): reminder of important risks and ... Posted 2020-08-27
The United Kingdom: Isotretinoin (Roaccutane): rare reports of erectile dysfunct... Posted 2017-10-27
Canada: Health Canada reinforces the importance of preventing pregnancy while ta... Posted 2016-09-08
 
back